BP529

依托度酸

British Pharmacopoeia (BP) Reference Standard

• 别名: 1,8-二乙基-1,3,4,9-四氢吡喃[3,4-b]吲哚-1-乙酸, NSC 282126, 依托度酸
• 经验公式（希尔记法）: C₁₇H₂₁NO₃
• CAS号: 41340-25-4
• 分子量: 287.35
• MDL號碼: MFCD00133313
• 分類程式碼代碼: 41116107
• NACRES: NA.24

属性

• 等級: pharmaceutical primary standard
• API 家族: etodolac
• 形狀: solid
• 儲存期限: limited shelf life, expiry date on the label
• 製造商／商標名: BP
• 應用: pharmaceutical
• 格式: neat
• 儲存溫度: 2-8°C
• SMILES 字串: CCc1cccc2c3CCOC(CC)(CC(O)=O)c3[nH]c12
• InChI: 1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)
• InChI 密鑰: NNYBQONXHNTVIJ-UHFFFAOYSA-N
• 基因資訊: human ... PTGS2(5743)

说明

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Etodolac BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Etodolac Capsules

生化／生理作用

非甾体类抗炎化合物，其是COX-1和COX-2的非选择性抑制剂。

包裝

Unit quantity: 150 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

其他說明

Sales restrictions may apply.

安全信息

• 象形圖: GHS06
• 訊號詞: Danger
• 危險聲明: H301
• 防範說明: P264 - P270 - P301 + P310 - P405 - P501
• 危險分類: Acute Tox. 3 Oral
• 儲存類別代碼: 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable